Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1999-01-29
2000-02-15
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
060253940
ABSTRACT:
Substituted indenyl sulfonyl acetic acids, amides, and alcohols are useful in the treatment of acne.
REFERENCES:
patent: 4393063 (1983-07-01), Moncada
patent: 4423075 (1983-12-01), Dvornik et al.
patent: 4751224 (1988-06-01), Agarwal et al.
patent: 5011843 (1991-04-01), Shell
patent: 5401754 (1995-03-01), Fujioka et al.
patent: 5401774 (1995-03-01), Pamukcu et al.
patent: 5500230 (1996-03-01), Nathanson
patent: 5858694 (1999-01-01), Piazza et al.
Menashi et al., The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A; FEBS Letters, 361 pp. 61-64 (1995).
Volpert et al., Captopril Inhibits Angiogenesis and Slows the Growth of Experimental Tumors in Rats; J. Clin. Invest., vol. 98, No. 3, pp. 671-679 (Aug. 1996).
Isner, Jeffrey, The Role of Angiogenic Cytokines in Cardiovascular Disease; Clinical Immunology and Immunopathology, vol. 80, No. 3, pp. S82-S91 (Sep. 1996).
Sakamoto et al., Effect of Intravitreal Administration of Indomethacin on Experimental Subretinal Neovascularization in the Subhuman Primate; Arch Ophthalmol, vol. 113, pp. 222-226 (Feb. 1995).
Tholen et al., Die Behandlung der altersabhangigen Makuladegeneration mit Interferon-.alpha.-2a; Opthalmologe, vol. 90, pp. 279-282, (1993).
Clements et al., Abstract, Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice; J Diabetes Complications, vol. 12(1), pp. 28-33 (Jan. 1998).
Vialettes et al., Perspectives D'Avenir Dans Le Traitement De La Retinopathie Diabetique; Diabete & Metabolisme, vol. 20, pp. 229-234 (1994).
Skopinska-Rozewska et al., Abstract, Inhibition of Angiogenesis by Sulindac and its Sulfone Metabolite (FGN-1): A Potential Mechanism For Their Antineoplastic Properties; Interscience World Conference on Inflammation, Antirheumatics, Analgesics, Immunomodulators; Geneva, Switzerland. May 19-21, 1997.
Mayle Mark Jeffrey
Menander Kerstin B.
Cell Pathways Inc.
Henley III Raymond
LandOfFree
Method for treating patients with acne by administering substitu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating patients with acne by administering substitu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating patients with acne by administering substitu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1906450